Business Context and Reporting Period
This Form 8-K filing by comScore, Inc. (Delaware corporation) reports on a material event occurring on March 18, 2013. The report details the completion of the sale of specific business assets to a third-party buyer.
Key Financial Metrics and Transaction Details
The filing focuses on the disposition of the "ARS Business" (ARS Non-Health Copy-Testing and Equity Tracking business) rather than standard quarterly operating metrics like revenue or net income.
- Total Purchase Price: $1,000,000.
- Payment Structure:
- $250,000 paid at closing (March 18, 2013).
- $250,000 due on the last day of June 2013.
- $250,000 due on the last day of September 2013.
- Final payment due on the last day of December 2013, subject to adjustments.
- Payment Adjustments: The final quarterly payment is reduced by approximately $87,000 for customer prepayments and may be further reduced by up to $100,000 for indemnification obligations.
The filing references unaudited pro forma consolidated financial information for the year ended December 31, 2012, giving effect to the disposition, but does not explicitly state the resulting revenue, profit, or cash flow figures in the text provided.
Material Changes Versus Prior Period
The primary material change is the divestiture of the ARS Business. This transaction alters the company's asset base and future revenue streams related to non-health copy-testing and equity tracking. The filing does not provide comparative financial data (e.g., year-over-year revenue or profit changes) for the company as a whole, only the terms of this specific asset sale.
Outlook, Risks, and Contingencies
Management Commentary: The filing confirms the transaction was completed as amended on March 18, 2013.
Contingencies and Risks:
- Indemnification: Future cash inflows are contingent on indemnification obligations, which could reduce the final payment by up to $100,000.
- Prepayments: A fixed reduction of approximately $87,000 applies to the final payment due to prior customer prepayments.
Unusual Items: The transaction involves a structured payment plan over four quarters rather than a single lump-sum closing payment.
Key Facts for Investor Verification
- Verify the receipt of the initial $250,000 closing payment and the schedule for subsequent quarterly payments.
- Review the unaudited pro forma financial information (Exhibit 99.1) to understand the impact of the divestiture on the 2012 fiscal year results.
- Monitor future filings for any adjustments to the final payment due to indemnification claims or the specific calculation of the $87,000 prepayment reduction.
- Confirm the cessation of revenue recognition from the ARS Non-Health Copy-Testing and Equity Tracking business post-closing.